Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

Rhea-AI Summary

Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for Q1 2022 on May 5, 2022, before market open. The conference call to discuss these results will be hosted by CEO Sean Browne and Interim CFO Scott Neils at 9:00 AM ET. Investors can access the call via dial-in or webcast. Xtant specializes in surgical solutions for spinal disorders, focusing on orthobiologics and spinal implant systems for complex spine procedures.

Positive

• Scheduled financial results release for Q1 2022 on May 5, indicating planned transparency.
• Company's focus on a comprehensive portfolio of spinal solutions, which may lead to future growth.

Negative

• No current financial metrics provided, leaving uncertainty regarding performance.

BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2022, before the open of the financial markets on Thursday, May 5, 2022.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Interim Chief Financial Officer, will host a conference call on Thursday, May 5 at 9:00 AM ET to review results.

Conference Details
Conference Date: Thursday, May 5, 2022 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q1 2022 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com

FAQ

When will Xtant Medical release its Q1 2022 financial results?

Xtant Medical will release its Q1 2022 financial results on May 5, 2022, before the market opens.

What time is the Xtant Medical Q1 2022 conference call?

The conference call is scheduled for May 5, 2022, at 9:00 AM ET.

How can I access the Xtant Medical Q1 2022 financial results conference call?

The conference call can be accessed via dial-in at 877-407-6184 or through a webcast registration.

What is Xtant Medical's focus in the medical technology industry?

Xtant Medical focuses on developing surgical solutions for spinal disorders, including orthobiologics and spinal implant systems.